Isoprocin glutarate

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameIsoprocin glutarate
Drug Alias NameIsoprocyn glutarateprodrug of 4-OH-DiPTLuvesilocinRE-104FT-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticAdjustment DisordersDepressive Disorder, Treatment-Resistant +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesReunion Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesReunion Neuroscience IncField Trip Health Ltd
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-TraumaticAdjustment DisordersDepressive Disorder, Treatment-Resistant +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A